FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Market Closed - BOERSE MUENCHEN 19:26:34 05/06/2024 BST | ||
| 8.01 EUR | +15.92% |
|
| Current month | +16.42% | ||
| 1 month | +10.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 05/06/24 | 8.01 | +15.92% |
| 04/06/24 | 6.91 | +7.63% |
| 03/06/24 | 6.42 | -6.69% |
| 31/05/24 | 6.88 | +1.47% |
| 30/05/24 | 6.78 | +6.27% |
Real-time BOERSE MUENCHEN
Last update June 05, 2024 at 07:26 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG3E3Q |
| ISIN | DE000GG3E3Q1 |
| Date issued | 02/02/2024 |
| Strike | 796.2 p |
| Maturity | Unlimited |
| Parity | 0.34 : 1 |
| Emission price | 13.55 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.2 € |
|---|---|
| Lowest since issue | 5.99 € |
| Spread | 0.7 € |
| Spread % | 8.00% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.13
USD
Average target price
16.45
USD
Spread / Average Target
+25.34%
- Stock Market
- Certificates
- Certificat